News und Analysen
Edison Inv Research Limited: Edison issues flash on Ergomed (ERGO)
Form 8.3 - Link Fund Solutions Ltd: Midatech Pharma PLC
Form 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Hardman & Co Research: Diurnal (DNL): $52.5m US deal strengthens balance sheet further
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Edison Investment Research Limited: Edison issues initiation on Ergomed (ERGO)
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
Hardman & Co Research: Diurnal (DNL): . and more to come (news flow)
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
Edison Investment Research Limited: Edison issues initiation on Silence Therapeutics (SLN)
DGAP-News: Ergomed plc: Lewis Cameron, ehemals Leiter der globalen klinischen Entwicklung bei Covance, zum Chief Operating Officer ernannt
Hardman & Co Research: Diurnal (DNL): Successful DITEST Phase I trial outcome
Hardman & Co Research: genedrive plc (GDR): Regulatory hurdle leaped: hearing loss assay
Hardman & Co Research: Diurnal (DNL): Approaching a number of near-term milestones
Hardman & Co Research: genedrive plc (GDR): Acceleration of news flow expected
Better Telecom Stock: AT&T vs. T-Mobile
AT&T (NYSE: T) and T-Mobile US (NASDAQ: TMUS) are two of the three major telcos that dominate the U.S. wireless market, but each arrived at that point from different places.
AT&T is a former Baby
3 High-Yield Dividend Stocks to Buy Hand Over Fist in May
Investors have enjoyed higher Treasury yields, serving up passive income over the past couple of years. However, there's still an abundance of quality dividend stocks that offer potential price
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Many healthcare investors look at Johnson & Johnson (NYSE: JNJ) and see a good, safe dividend stock. But I see an investment that's full of uncertainty and risk.
The company continually runs into
Could AT&T Stock Help You Retire a Millionaire?
Retiring wealthy isn't necessarily about hitting the home run investment. Instead, it can be about consistently hitting singles and doubles over time.
U.S. telecom company AT&T (NYSE: T) probably
Want an Extra $500 in Annual Dividend Income? Invest $5,890 in These 3 High-Yield Dividend Stocks.
Investors eager to bulk up their passive income streams can do so without breaking the bank.
At recent prices, Hercules Capital (NYSE: HTGC), Altria Group (NYSE: MO), and AT&T (NYSE: T) offer an
1 Wall Street Analyst Thinks AT&T Stock Is Going to $20. Is It a Buy?
AT&T (NYSE: T) stock has struggled in recent years, but Barclays analyst Kannan Venkateshwar believes the company deserves a higher valuation, considering the recent subscriber gains for its
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)Q1 2024 Earnings CallMay 01, 2024, 8:00 a.m. ET
Operator
Source Fool.com